La biologia molecolare nella diagnosi e nella valutazione della malattia residua minima nella leucemia linfoblastica acuta del bambino

Translated title of the contribution: Molecular biology in the diagnosis and evaluation of minimal residual disease in pediatric acute lymphoblastic leukemia

M. Lanciotti, C. Micalizzi, F. Scuderi, D. Di Martino, G. Dini

Research output: Contribution to journalArticlepeer-review

Abstract

The molecular approach to the study of minimal residual disease (MRD) in pediatric acute lymphoblastic leukemia (ALL) underlines the importance of the molecular techniques in the hematology and oncology fields. The possibility to reach a 'molecular remission' after the induction therapy is the most important goal to cure the leukemia. We report the most frequently used markers for MRD detection in pediatric ALL and the results obtained.

Translated title of the contributionMolecular biology in the diagnosis and evaluation of minimal residual disease in pediatric acute lymphoblastic leukemia
Original languageItalian
Pages (from-to)56-69
Number of pages14
JournalGaslini
Volume33
Issue number1
Publication statusPublished - 2001

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Molecular biology in the diagnosis and evaluation of minimal residual disease in pediatric acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Cite this